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Outbreaks of infectious diseases may occur in animal and human populations;
this underlines the need for suitable One Health approaches. During outbreak
situations, straightforward identification of etiological agents is indispensable for taking
countermeasures. A recently published protocol for metagenomic virus detection in
clinical specimens (TUViD-VM) was developed for snap-frozen tissues which can be
challenging to obtain. Here, we describe the use of RNALater R©-treated tissue at ambient
temperatures for virome sequencing. This study demonstrates that samples stored in
RNALater R© buffer yield similar results to those stored snap-frozen.
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THE STUDY
Identification of etiological agents is of high importance when assessing outbreak situations. One
of the challenges in One Health diagnostic is that detection methods are often only validated and
available for human samples or samples from certain animal species. When these specific virus
detection approaches fail, unbiased sequencing methods are often used to increase the chance
of pathogen detection. So far, approaches for virus enrichment prior to sequencing are being
based on native snap-frozen samples (Kohl et al., 2015). This is due to the fact that most of the
protocols are using any kind of mechanical separation step between the actual virus particles and
undesired background. Mechanical separation or enrichment (i.e., ultracentrifugation, filtration,
centrifugation or digestion of background genome) requires intact virus particles. Particle
structures are best preserved at very low temperatures. In the field, these cooling requirements
are sometimes challenging as liquid nitrogen or dry ice is often difficult to obtain, hard to transport
or not available at all. However, even if snap-freezing were available in the field, the transportation
of the samples at such low temperatures via aircraft would remain a further costly challenge.
To overcome these difficulties, we evaluated the application of the TUViD-VM protocol
on samples preserved in RNALater R© RNA Stabilization Reagent (Qiagen, Hilden, Germany).
RNALater R© is widely used for tissue archiving and stabilization of RNAs. Qiagen states that
tissue RNA is protected in RNALater R© for 7 days at 15–25◦C, for 4 weeks at 2–8◦C and for
longer periods at −20◦C or −80◦C (1last accessed 17th of August 2017). Additionally, it has
been shown that the protection of RNA in RNALater R© at ambient temperatures is equivalent
to that by snap-freezing in liquid nitrogen (Mutter et al., 2004; Wang et al., 2006). Moreover,
other studies showed that RNALater R© may also be able to preserve the infectivity of viral particles
1https://www.qiagen.com/de/resources/resourcedetail?id=19988eb0-6df5-4d26-8435-33efe98197da&lang=en
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FIGURE 1 | Reproducibility and variation during the TUViD-VM purification
method. Duplicates were measured for the presence of SeV RNA during
different stages of TUViD-VM purification to evaluate the reproducibility of the
method.
FIGURE 2 | Description of the purification procedure for comparative NGS. All
preparations started with the SeV infectious liver tissue aliquots prepared and
validated before. A native aliquot was forwarded to NGS without additional
purification procedure. A snap-frozen aliquot was thawed and diluted with
100 µl of PBS and purified by TUViD-VM before NGS as described before. An
RNALater R© aliquot was thawed and diluted with 100 µl of RNALater R© and
kept at ambient conditions for 7 days before TUViD-VM and NGS. The left Y
axis indicates the total number of SeV reads obtained by NGS, normalized to
a total of 1,000,000 reads. The right Y axis indicates the genome coverage of
SeV, revealed by mapping the reads to the reference genome of SeV
(accession number KT120023). This likely underestimates the true number of
reads present by possibly unmapped reads due to rapid mutation rate of RNA
viruses and thus divergence from the selected reference genome. RT, Room
temperature.
(and therefore the structure) at ambient conditions over a longer
period of time (Uhlenhaut and Kracht, 2005; Kurth, 2007).
In this study we evaluated the use of RNALater R©-preserved
tissues stored at ambient temperatures as starting material
for unbiased virus purification protocols and metagenomic
sequencing (TUViD-VM).
Embryonated chicken eggs were infected with Sendai virus
(SeV) strain Hei, and livers were extracted, homogenized and
validated as described before (Kohl et al., 2015).
Liver homogenates (52 copies/µl for SeV) were stored in
aliquots of 100 µl at−80◦C. First, the integrity of the aliquots was
evaluated. Additionally, the reproducibility of the TUViD-VM
method was demonstrated in four independent preparations
shown in Figure 1. For validation of the TUViD-VM in
RNALater R© samples, these aliquots were used either snap frozen
or stored in RNALater R© at ambient temperature and prepared in
duplicate as depicted in Figure 2.
The samples were analyzed for the presence of SeV and
the TATA-box-binding protein (TBP) housekeeping gene
prior to sequencing as described previously (Kohl et al.,
2015). For the native/non-enriched sample duplicates, the CT
values were similar (SeV 52 copies/µl, TBP 226 copies/µl),
the snap-frozen duplicates and the RNALater duplicates
showed similar results (SeV 1.3∗107 copies/µl, TBP = 0 and
1.0∗107 copies/µl, TBP = 0), respectively. For metagenomic
sequencing, one of the equal duplicates was randomly picked
and sequenced on the Personal Genome Machine (PGM)
and analyzed as described for the TUViD-VM protocol
(Kohl et al., 2015). The total number of SeV reads in the
snap-frozen sample was 136,441 and in the RNALater sample
198,715, respectively. These reads covered 88.1 percent and
98.8 percent of the SeV genome, respectively (Figure 2).
In comparison, the native sample, not undergoing further
purification, resulted in 4 SeV reads (6 percent of SeV
genome).
We demonstrated the feasibility of using RNALater R©-stored
tissue homogenates (and possibly other fluid sample material)
as basis for metagenomic sequencing. PCR and sequencing
results for the RNALater R©-stored samples are similar to results
obtained with snap-frozen samples. Investigators are aiming to
preserve their samples in the best way possible. Using snap-
frozen samples in field settings and outbreak investigations is
the predominant procedure. Snap-freezing is often challenging
as it requires extra equipment and costly transportation.
Dry ice and liquid nitrogen has to be available to keep
samples at ultra-low temperatures. Dry shippers are a safe
and lasting way to transport samples in liquid nitrogen,
but beside the problem of unavailability of liquid nitrogen,
the shipper has to be charged in advance. Also it can be
difficult and expensive to transport the shipper on a passenger
plane, due to dangerous goods regulations and heavy weight.
Often only transport via air freight is possible, at even
higher costs. We showed that RNAlater R© storage can help
to overcome these drawbacks for metagenomic sequencing.
RNALater R©-preserved tissue homogenates can be stored for
at least 7 days at ambient temperature without any loss in
detectability. However, a study conducted by Riesgo et al.
(2012) on preservation of sponge tissue described a potential
storage limit of even 1 month for RNA preserved samples.
Storing samples in RNAlater R© at ambient temperatures will
also increase the possible amount of samples for transportation
during outbreak situations, which would be of further benefit in
the context of One Health. This all together represents a major
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advantage for researchers using metagenomic sequencing in virus
discovery, outbreak settings and One Health.
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